Clinical Trial Update: Fotemustine and Dacarbazine Versus Dacarbazine +/- Alpha Interferon in Advanced Malignant Melanoma [Phase 3]

View source ↗

Summary

Phase 3 trial comparing fotemustine and dacarbazine to dacarbazine with or without alpha interferon in advanced malignant melanoma has completed with results po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Melanoma
• Melanoma

Drugs mentioned

• Alpha Interferon (interferon alfa)
• Dacarbazine (dacarbazine)
• Fotemustine (fotemustine)

Snippet

Sponsor: National Cancer Institute, Naples | Conditions: Malignant Melanoma, Recurrent Melanoma | Phase 3 | Status: COMPLETED | Results posted: 2020-11-13